RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 42 filers reported holding RECRO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $169,987 | -25.3% | 484,985 | 0.0% | 0.12% | -33.9% |
| Q3 2023 | $227,458 | -37.1% | 484,985 | +47.4% | 0.19% | -30.5% |
| Q2 2023 | $361,887 | +127.0% | 328,988 | +145.5% | 0.27% | +119.4% |
| Q1 2023 | $159,446 | +30.5% | 133,988 | +63.4% | 0.12% | +34.8% |
| Q4 2022 | $122,162 | – | 81,988 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
| Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
| Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
| AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
| Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
| Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
| TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
| Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
| Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |